White House Reverses Course, Approves New FDA COVID-19 Vaccine Guidelines Published: Oct. 7, 2020 By Alex Keown BioSpace The White House has reversed its position on new vaccine guidelines proposed by the U.S. Food and Drug Administration. The approval of the new guidelines all but assures that a vaccine for the novel coronavirus that has […]
President Donald Trump signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations and expanding the scope of a July 2020 action.
White House Executive Order Aims to Boost Domestic Production of ‘Essential Drugs’
“Essential Drugs”, Association for Accessible Medicines, Biopharmaceutical, Business, Center for Drug Evaluation and Research (CDER), Donald Trump, Executive Orders, Federal Agencies, Manufacturing, Medical Supplies, PhRMA, Politico, Prescription Drug Costs, Prescription Medicines, Therapeutics, United States, White HouseIn an aim to create a strong domestic supply chain, President Donald Trump signed an Executive Order that calls for federal agencies to purchase “essential drugs” and medical supplies that are produced in the United States, rather than from abroad as is the current practice.
A meeting with top pharmaceutical executives that President Donald Trump promised wasn called off, a White House official said.
Biopharma Industry News: Update on the Novel Coronavirus
Artificial Intelligence, Biopharma, Business, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, Government, Life Sciences, Messenger RNA (mRNA) Vaccines, Partnerships, PhRMA, Quarantine, R&D, Test Kits, Tests, World Health OrganizationAs the number of diagnosed cases of COVID-19 continues to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization.
The Trump administration secured commitments from top pharmaceutical companies to work together to develop a vaccine and treatments to fight the coronavirus.
As the J.P. Morgan Healthcare Conference continues to roll on with companies showcasing their pipelines and business plans, negative reports about the host city San Francisco have been made.
Vaccines: A Healthcare Revolution and High Return on Investment
Business, Chickenpox Virus, Clinical Trials, Deals, Dengue Fever, Diphtheria, Diseases, Haemophilus influenza type B, Hepatitis A, Hepatitis B, Infectious Diseases, Influenza, Measles, Mumps & Rubella, pertussis, Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA, Pneumococcal Disease, Polio, Product Pipelines, R&D, Rotavirus, Smallpox, tetanus, U.S. Centers for Disease Control and Prevention, Vaccines, Viruses, Whooping Cough, World Health OrganizationAccording to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are 264 vaccines in development to prevent and treat diseases.
Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma
Bankruptcy, Biotech, Bioterrorism, Births, Business, Carcinogens, China, CRISPR, Fraud, Gene Editing, Genes, Government, HIV, Medicare, N-nitrosodimethylamine (NDMA), Opioids, Pharma, PhRMA, Restructuring, Spinal Muscular Atrophy (SMA), StudiesFor Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.
PhRMA CEO Stephen Ubl said House Speaker Nancy Pelosi’s plan would be “devastating” to the industry.